initiated: BofA Securities Recommends Sutro Biopharma Inc (NASDAQ:STRO) Stock to “a Buy”
BofA Securities raised the price target for the Sutro Biopharma Inc (NASDAQ:STRO) stock to “a Buy”. The rating was released on May 08, 2024, according to finviz. The research report from Oppenheimer has initiated the stock to Outperform, with a price target set at $10. The stock was downgraded by Wells Fargo, who disclosed in […]
Earnings and valuation of Sutro Biopharma Inc (STRO) Stock are impressive
BofA Securities raised the price target for the Sutro Biopharma Inc (NASDAQ:STRO) stock to “a Buy”. The rating was released on May 08, 2024, according to finviz. The research report from Oppenheimer has initiated the stock to Outperform, with a price target set at $10. The stock was downgraded by Wells Fargo, who disclosed in […]
The Underside Of Sutro Biopharma Inc (STRO) Stock Is A Little Uncertain
BofA Securities raised the price target for the Sutro Biopharma Inc (NASDAQ:STRO) stock to “a Buy”. The rating was released on May 08, 2024, according to finviz. The research report from Oppenheimer has initiated the stock to Outperform, with a price target set at $10. The stock was downgraded by Wells Fargo, who disclosed in […]
A fresh round of sideways trading continues for Sutro Biopharma Inc (STRO) Stock.
BofA Securities raised the price target for the Sutro Biopharma Inc (NASDAQ:STRO) stock to “a Buy”. The rating was released on May 08, 2024, according to finviz. The research report from Oppenheimer has initiated the stock to Outperform, with a price target set at $10. The stock was downgraded by Wells Fargo, who disclosed in […]
A New Look at Sutro Biopharma Inc (STRO) Stock’s Hidden Strategies
BofA Securities raised the price target for the Sutro Biopharma Inc (NASDAQ:STRO) stock to “a Buy”. The rating was released on May 08, 2024, according to finviz. The research report from Oppenheimer has initiated the stock to Outperform, with a price target set at $10. The stock was downgraded by Wells Fargo, who disclosed in […]
Sutro Biopharma Inc (NASDAQ:STRO) stock Posted Operating Margin of -67.27 percent in Last Year: Is Admissible?
BofA Securities raised the price target for the Sutro Biopharma Inc (NASDAQ:STRO) stock to “a Buy”. The rating was released on May 08, 2024, according to finviz. The research report from Oppenheimer has initiated the stock to Outperform, with a price target set at $10. The stock was downgraded by Wells Fargo, who disclosed in […]
Sutro Biopharma Inc (STRO) Stock Is Emerging from the Clouds
BofA Securities raised the price target for the Sutro Biopharma Inc (NASDAQ:STRO) stock to “a Buy”. The rating was released on May 08, 2024, according to finviz. The research report from Oppenheimer has initiated the stock to Outperform, with a price target set at $10. The stock was downgraded by Wells Fargo, who disclosed in […]
